RESUMO
Antibiotic therapy with colbiocin of chronic purulent mesotympanitis achieved a response rate of 92%, recurrence-free interval reached 6 months in 84% of the treated patients. This allows to recommend colbiocin as a drug of choice in hospital and outpatient treatment of chronic purulent mesotympanitis.
Assuntos
Cloranfenicol/uso terapêutico , Colistina/uso terapêutico , Quimioterapia Combinada/uso terapêutico , Otite Média Supurativa/tratamento farmacológico , Tetraciclina/uso terapêutico , Doença Crônica , HumanosAssuntos
Abscesso Encefálico/diagnóstico por imagem , Lobo Frontal/diagnóstico por imagem , Tomografia Computadorizada por Raios X/métodos , Adulto , Abscesso Encefálico/complicações , Abscesso Encefálico/cirurgia , Lobo Frontal/cirurgia , Humanos , Masculino , Mastoidite/complicações , Mastoidite/cirurgia , Pólipos Nasais/complicações , Pólipos Nasais/cirurgia , Otite Média Supurativa/complicações , Otite Média Supurativa/cirurgia , Sinusite/complicações , Sinusite/cirurgiaRESUMO
The responses to sorption treatment have been analysed for 373 patients suffering from staphylococcal, allergic, purulent, polypous-purulent rhinosinusitis. For enterosorption a coal spherical phi EH sorbent was used. Application sorption was performed with fabric sorbent AYT-M2, nonfabric sorbent AHM-pi, dust phi EH sorbent. Gelevin was tried for tampon-free postoperative management after dissection of the paranasal sinuses. Sorbents application advances the efficacy of nasal and paranasal disease treatment.